MGManuela Gantiva

Manuela Gantiva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Manuela Gantiva has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Guía para el diagnóstico y el tratamiento de hipoacusia neurosensorial súbita idiopática (sordera súbita)

    by Angela María Ronderos Suárez, María Manuela Gantiva Navarro, Adriana Yelitza Isaza Marín, Ángela María Campos Mahecha

    The specific definition is a unilateral or bilateral sensorineural hearing loss greater than 30 dB that affects at least three consecutive audiometric frequencies and develops in a period less than or equal to 72 hours, most of which is idiopathic (2). It affects 5 to 27 per 100,000 people per year. The causes of sudden sensorineural hearing loss are classified as primary and secondary. Treatment includes systemic and topical corticosteroids, antiviral agents, hyperbaric oxygen therapy, vasodilatory agents, diuretics and other medications as complementary alternative treatments (5).


  • Open Access

    Factors associated with allergic rhinitis and combined allergic rhinitis and asthma syndrome (CARAS) in adults undergoing immunotherapy in a tropical country: Is ISAAC-III questionnaire useful in adult populations?

    by Augusto Peñaranda, Lucía C. Pérez-Herrera, Manuela Gantiva, Sergio Moreno-López, Julian Manrique, Daniel Peñaranda, Elizabeth García

    Background: Allergic diseases affect about 10–30% of the population in low- or middle-income tropical countries. Few studies describe the factors associated with allergic diseases in adult patients undergoing immunotherapy in Latin American countries. Objective: This study aimed to determine the factors associated with allergic rhinitis (AR) and AR in comorbidity with asthma (CARAS) in adults treated with immunotherapy in two allergy referral centers in Bogotá (Colombia). Material and Methods: Observational, cross-sectional study conducted between January 2018 and January 2019. ISAAC-III and sociodemographic questionnaires were applied to determine the factors associated with AR and CARAS in adults treated with immunotherapy who attended the allergy consult at the Fundación Santa Fe de Bogotá and Unimeq-Orl. Results: Among 416 adults aged 18–68 years, 71.4% (n = 297) were women. Regarding the sensitization results obtained by skin prick test, the most frequent allergens were house dust mites (64.18%): 49.03% were positive for both Dermatophagoides pteronyssinus and Dermatophagoides farinae, while 28.61% were positive for Blomia tropicalis. Excluding house dust mites, the most frequent allergens were dog hair (31.01%), cat hair (15.1%), grasses (15.9%), and food (15.9%). The main factor associated with exclusive AR was regular acetaminophen use more than four times a year: Prevalence ratio (PR) = 1.77 (95% CI: 1.12–2.25). The main factor associated with CARAS was cesarean delivery PR: 1.44 (95% CI: 1.09–1.78). Conclusion: The main factor associated with AR was regular acetaminophen use, while that associated with CARAS was cesarean delivery. The ISAAC-III questionnaire can be a useful low-cost tool to assess the factors associated with allergic diseases in adults in tropical countries.


  • Open Access

    Factors associated with allergic rhinitis and combined allergic rhinitis and asthma syndrome (CARAS) in children aged 5–18 years undergoing immunotherapy in a tropical low- or middle-income country

    by Augusto Peñaranda, Manuela Gantiva, Sergio Moreno-López, Daniel Peñaranda, Lucia C. Perez-Herrera, Elizabeth Garcia

    Background: Tropics have some particularities that can impact the natural history and fac-tors associated with allergic diseases. However, few studies described the characteristics of patients with allergic rhinitis (AR) and combined AR and asthma syndrome (CARAS) in Latin American tropical countries. Objective: This study aimed to determine the medical, social, and environmental factors associated with AR and CARAS in children aged 5–18 years treated with immunotherapy in two allergy referral centers in Bogotá (Colombia).Material and methods: An observational, cross-sectional study was conducted between January 2018 and January 2019. International Study Asthma Allergies Childhood-III and socio-demographic questionnaires were applied to adolescents and parents of children undergoing immunotherapy at the allergy consult in the Hospital Universitario Fundación Santa Fe de Bogotá and UNIMEQ-ORL. Results: Among 830 children aged 5–18 years, 38.1% (n = 316) were women. Up to 63.25% of the population had a positive skin prick test for house dust mites: 63.25% for Dermatophagoides pteronyssinus, 61.81% for Dermatophagoides farinae, and 31.57% for Blomia tropicalis. The fac-tors associated with AR were male sex (PR: 1.31, 95% CI: 1.08–1.57), antibiotic consumption during the first year of life (PR: 0.80; 95% CI: 0.63–0.99), and exposure to dogs (PR: 1.32; 95% CI: 1.06–2.66). The factors associated with CARAS were older age (PR=0.95; 95% CI: 0.95–0.99), acetaminophen consumption over four times a year (PR: 1.31; 95% CI: 1.03–1.55), and antibiotic consumption during the first year of life (PR: 1.21; 95% CI: 1.06–1.34). Conclusion: A high prevalence of B. tropicalis was found in this study. The factors associated with AR and CARAS are like those described in high-income tropical countries. Further studies are needed in low- or middle-income tropical countries to identify modifiable factors associ-ated with allergic diseases.


  • Open Access

    Isolated facial palsy after Chikungunya infection: A novel differential diagnosis

    by Augusto Peñaranda, Daniel Peñaranda, María M. Gantiva-Navarro, Lucía C. Pérez-Herrera

    A significant raise in the reports of neurological manifestations due to Chikungunya virus has been described worldwide. Here, we describe a case report of a previously healthy young adult who developed isolated left facial palsy after a confirmed Chikungunya virus infection in the Colombian tropics. We suggest considering this virus as a differential diagnosis for facial palsy in patients with confirmed Chikungunya virus infection who live in endemic regions or report a history of recent travel to these regions.